A new study provides reference standards for clinical evaluations.
Corrigan Minehan Heart Center
Spontaneous Coronary Artery Dissection (SCAD)
Explore This Treatment Program
Overview: A Multidisciplinary Approach
Spontaneous coronary artery dissection (SCAD) is a rare condition that occurs when a tear forms in one or more blood vessels of the heart, which can slow or block blood flow to the heart and cause a heart attack. Although SCAD may seem similar to other conditions that cause heart attacks, it is a unique disorder that should be managed and monitored by specialists with expertise in the disease.
At the Elizabeth Anne and Karen Barlow Corrigan Women’s Heart Health Program in the Massachusetts General Hospital Corrigan Minehan Heart Center, a multidisciplinary team that includes experts in cardiology, vascular medicine and genetics works together to conduct a comprehensive evaluation in order to develop a treatment plan that is personalized to each patient's particular condition.
In the majority of cases, SCAD is treated with medications. In some cases, open heart surgery or a stent is needed. As part of your assessment, our team may recommend diagnostic testing with genetic screening and specialized imaging studies in order to define potential causes for your SCAD. We will also determine the best medications to treat your condition and follow you closely for the long term. Our team is dedicated to working with you to develop a treatment approach that allows you to lead an active life.
The Patient Experience
During your first consultation, your care team will conduct a physical examination and review your medical history. If you are a new patient, we ask that you bring a list of the medications, vitamins and herbal supplements that you take, along with information on dosages. Additionally, please bring any medical records, CDs of images, consultation notes, and notes on previous treatments and their effectiveness. We use this information at the time of your first visit to get a complete picture of your overall condition in order to develop an appropriate treatment plan.
We may recommend additional testing if needed and will help schedule your appointments. Our team will collaborate with your referring physician and ensure that she or he is aware of any test results and next steps in your treatment.Additional SCAD Resources:
One Call Coordinates Care
Our dedicated nurse coordinator is available Monday through Friday from 8:30 am-5:00 pm to take relevant information about your condition and make a timely appointment with our team. Call 866-644-8910 to speak to the nurse coordinator or request an appointment online.
Advancing SCAD Research
As an academic medical center, Mass General is committed to studying diseases and developing new approaches in treatment. Our researchers are leaders within their respective fields and collaborate with colleagues in various departments across the hospital. As a patient, you can benefit from shared expertise, leading research, and our commitment to quality and excellence.
The goal of the SCAD research at Mass General is to determine potential causes of the disease as well as how to best manage this condition. Our researchers are committed to finding ways to improve the quality of life of patients with SCAD.
Our research aims to:
- Determine if there is a gene or genes that may be associated with SCAD
- Study exercise protocols to determine what type of cardiac rehabilitation to offer SCAD patients
- Evaluate the psychosocial impact of a SCAD diagnosis in order to develop mind/body interventions to help patients cope with the diagnosis
- Evaluate the utility of different imaging tools in the treatment of SCAD
If you have SCAD and wish to participate in our SCAD research studies or request further information regarding our research registry, please contact Shernette Wood, at firstname.lastname@example.org or 866-644-8910.
The Mass General Difference
Mass General is consistently ranked among the best hospitals in the country by U.S. News & World Report. Our ranking is based on our quality of care, patient safety and reputation in 16 different specialties. Our commitment to excellence means that we work to ensure that you receive the best care at all points during your visit. Our SCAD team works in close contact with your other physicians to ensure a coordinated, seamless experience.
Meet Our Team
Learn more about the doctors treating Spontaneous Coronary Artery Dissection (SCAD)
- Director, Coronary Intervention, Massachusetts General Hospital
- Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program
- Associate Physician, MGH Cardiology, Department of Medicine
- Department of Pediatrics
- Section Head, Vascular Medicine and Intervention
- Chairman, STEMI & Acute MI Quality Improvement Committee
- Department of Medicine
- Co-Director Corrigan Women's Heart Health Program
- Co-Director MGH Cardiovascular Disease and Pregnancy Service
- Department of Medicine
- Director, Vascular Medicine Fellowship
- Co-Director, Corrigan Women's Heart Health Program
- Staff Story
- Dec | 16 | 2020
Janet Ma, MD, is a first-year fellow in the Cardiovascular Disease Fellowship Program at Massachusetts General Hospital. Dr. Ma explains what inspired her to come to Mass General, to pursue a career in medicine and her work to improve equity in health care.
- Press Release
- Nov | 16 | 2020
Short bursts of physical exercise induce changes in the body’s levels of metabolites that correlate to, and may help gauge, an individual’s cardiometabolic, cardiovascular and long-term health.
- Press Release
- Nov | 11 | 2020
New research by investigators at Massachusetts General Hospital (MGH) reveals considerable uncertainty in how to care for patients with a certain type of heart attack.
- Press Release
- Nov | 10 | 2020
Study reveals reveals women with premature menopause often exhibit certain blood cell changes that elevate their risk of developing coronary artery disease.
- Oct | 9 | 2020
Mass General and Newton-Wellesley Hospital staff have been working together for the past eight months to ensure a safe, efficient and thoughtful transition plan for the more than 600 anticoagulation patients who will now receive their care at the MGH AMS Clinic.